ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.888,57
-0,14%
S&P 500
5.930,85
1,09%
Dow Jones
42.840,26
1,18%
Euro vs US Dollar
1,04118
-0,20%
Bitcoin
95.957,46
0,89%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Alpha Tau Medical Ltd (DRTS) Börsenkurse

Alpha Tau Medical Ltd

Alpha Tau Medical Ltd (DRTS)

NASDAQ
3,10
-0,03
(-0,80%)
Geschlossen 21 Dezember 10:00PM
Verzögert um 15 Minuten
3,10
0,00
( 0,00% )
Vor Marktöffnung: 10:05AM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
3,10
Gebot
3,00
Fragen
4,94
Volumen
-
0,00 Tagesbereich 0,00
1,75 52-Wochen-Bereich 3,40
Marktkapitalisierung
215,979M
Handelsende
3,10
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
35.619
Ausgegebene Aktien
69.670.612
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-7,41
Gewinn pro Aktie (EPS)
-0,42
Erlöse
-
Nettogewinn
-29,16M

Über Alpha Tau Medical Ltd

Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Website
www.alphatau.com
Hauptsitz
Jerusalem, Jerusalem, Isr
Gegründet
-
Alpha Tau Medical Ltd is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker DRTS. The last closing price for Alpha Tau Medical was US$3,10. Over the last year, Alpha Tau Medical shares have traded in a share price range of US$ 1,75 to US$ 3,40.

Alpha Tau Medical currently has 69.670.612 shares in issue. The market capitalisation of Alpha Tau Medical is US$215,98 million. Alpha Tau Medical has a price to earnings ratio (PE ratio) of -7.41.

DRTS Neueste Nachrichten

Weitere Nachrichten

Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day

JERUSALEM, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

18 Dezember 2024
GlobeNewswire Inc.

Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

JERUSALEM, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha...

17 Dezember 2024
GlobeNewswire Inc.

Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference

JERUSALEM, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

11 Dezember 2024
GlobeNewswire Inc.

Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium

JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

06 Dezember 2024
GlobeNewswire Inc.

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

- Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha DaRT® for patients with recurrent glioblastoma...

19 November 2024
GlobeNewswire Inc.

Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference

JERUSALEM, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

13 November 2024
GlobeNewswire Inc.

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

JERUSALEM, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-emitters cancer therapy Alpha...

21 Oktober 2024
GlobeNewswire Inc.

Alpha Tau Treats First Patient with Recurrent Lung Cancer

JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

10 Oktober 2024
GlobeNewswire Inc.

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

JERUSALEM, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

20 September 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

22 August 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0852.81923714763.0153.23432503.13640826CS
40.7632.47863247862.343.22.34627012.93864739CS
120.834.78260869572.33.22.11356192.6482372CS
260.8437.16814159292.263.21.75337202.4301471CS
520.13.3333333333333.41.75344262.62340574CS
156-8.45-73.160173160211.5520.651.75935268.84903502CS
260-8.45-73.160173160211.5520.651.75935268.84903502CS

DRTS - Frequently Asked Questions (FAQ)

What is the current Alpha Tau Medical share price?
The current share price of Alpha Tau Medical is US$ 3,10
How many Alpha Tau Medical shares are in issue?
Alpha Tau Medical has 69.670.612 shares in issue
What is the market cap of Alpha Tau Medical?
The market capitalisation of Alpha Tau Medical is USD 215,98M
What is the 1 year trading range for Alpha Tau Medical share price?
Alpha Tau Medical has traded in the range of US$ 1,75 to US$ 3,40 during the past year
What is the PE ratio of Alpha Tau Medical?
The price to earnings ratio of Alpha Tau Medical is -7,41
What is the reporting currency for Alpha Tau Medical?
Alpha Tau Medical reports financial results in USD
What is the latest annual profit for Alpha Tau Medical?
The latest annual profit of Alpha Tau Medical is USD -29,16M
What is the registered address of Alpha Tau Medical?
The registered address for Alpha Tau Medical is KIRYAT HAMADA ST. 5, JERUSALEM, JERUSALEM, 9777605
What is the Alpha Tau Medical website address?
The website address for Alpha Tau Medical is www.alphatau.com
Which industry sector does Alpha Tau Medical operate in?
Alpha Tau Medical operates in the SURGICAL,MED INSTR,APPARATUS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PHIOPhio Pharmaceuticals Corporation
US$ 4,19
(138,07%)
3,03M
EDBLEdible Garden AG Inc
US$ 0,4753
(99,96%)
18,16M
ADGMAdagio Medical Holdings Inc
US$ 3,03
(83,64%)
1,44M
RUMRumble Inc
US$ 10,56
(46,87%)
590,84k
ABATAmerican Battery Technology Company
US$ 1,63
(42,98%)
2,86M
TCBSTexas Community Bancshares Inc
US$ 11,005
(-27,07%)
206
WHLMWilhelmina International Inc
US$ 3,13
(-24,21%)
300
ONFOOnfolio Holdings Inc
US$ 1,23
(-23,13%)
6,26k
HSDTHelius Medical Technologies Inc
US$ 0,70
(-23,08%)
148,11k
NIXXNixxy Inc
US$ 3,70
(-20,43%)
1
EDBLEdible Garden AG Inc
US$ 0,4753
(99,96%)
18,16M
LAESSEALSQ Corporation
US$ 3,62
(31,64%)
7,98M
NITON2OFF Inc
US$ 0,212
(17,13%)
5,81M
PHIOPhio Pharmaceuticals Corporation
US$ 4,18
(137,50%)
3,03M
ABATAmerican Battery Technology Company
US$ 1,63
(42,98%)
2,86M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
DRTS
Alpha Tau Medical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten